The Ohio State University Wexner Medical Center and Arthur G. James Comprehensive Cancer CenterColumbus, Ohio, United States
Disclosure information not submitted.
ORF08-05 - Real-World Effectiveness of Burosumab in Adults with X-Linked Hypophosphatemia (XLH): An Item-Level Analysis of the Western Ontario and McMaster Universities Osteoarthritis Index
Saturday, June 13, 202610:15 AM - 10:30 AM CT
ORF16-04 - Encaleret Restores Mineral Homeostasis in Autosomal Dominant Hypocalcemia Type 1 (ADH1): Primary Results from the Phase 3 CALIBRATE Trial
Saturday, June 13, 20262:00 PM - 2:15 PM CT
MON-771 - Improvements in Patient-Reported Outcomes With Eneboparatide in Chronic Hypoparathyroidism Over 1 Year: A Phase 3, Randomized, Placebo-Controlled and Open-Label Study Assessing the Efficacy and Safety of Eneboparatide (CALYPSO)
Monday, June 15, 20269:00 AM - 2:00 PM CT
.jpg)
.jpg)